24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiomX
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:43
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
21:16
Nervio appoints Dr. Richard Vogel as US CEO
19:06
Paragon’s $900M sale in limbo as Defense Ministry steps in
15:05
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
2
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
3
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
4
Israel will "experience a 'baby boom' of innovation" in 2025, says RUNI Ventures
5
The Wiz of GenAI security? “Lasso has the potential to be a once-in-a-decade company in cyber”
More news
BiomX
3 stories about BiomX
Biomed Company BiomX Merges With New York-Listed Chardan Healthcare
17.07.19
|
Meir Orbach
BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease
Phage Therapies Company BiomX Raises $32 Million
20.02.19
|
Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics
Please ensure Javascript is enabled for purposes of
website accessibility